Randomized Two-Stage Phase II Clinical Trial Designs Based on Barnard's Exact Test

By Shan Guogen   Ma Changxing   Hutson Alan D.   Wilding Gregory E.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1081-1090

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Two-Stage Designs Allowing Flexibility in Number of Subjects for Phase II Clinical Trials

By Masaki Nobuyuki  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 721-731

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Blood Sampling Time Windows for Parameter Estimation Using a Population Approach: Design of a Phase II Clinical Trial

By Chenel Marylore   Ogungbenro Kayode   Duval Vincent   Laveille Christian   Jochemsen Roeline   Aarons Leon  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 737-756

Springer Publishing Company

Access to resources Recommend Favorite

Optimal Two-Stage Randomized Multinomial Designs for Phase II Oncology Trials

By Sun Linda  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 485-493

Taylor & Francis Ltd

Access to resources Recommend Favorite

A woman enrolled in the fingolimod arm of the phase III FREEDOMS II trial developed severe haemorrhagic focal encephalitis.

By  

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite